We could not find any results for:
Make sure your spelling is correct or try broadening your search.
– Completed US$7.7 million financing and reverse takeover to take Company public – Chinese partner achieved regulatory approval, setting stage for royalty stream and triggering US$5.9 million...
– Marks first time as a public company that Conavi is presenting at an investor event – – Live webcast presentation on Wednesday, December 11ᵗʰ at 3:35 p.m. ET – TORONTO, Dec. 10, 2024 (GLOBE...
– Approval triggers fourth and final US$5.9 million milestone payment to Conavi Medical, which it will use to extinguish the promissory note owed by it to EOM – – Conavi Medical eligible to...
– Conavi Medical’s Novasight Hybrid™ System is the first technology to combine both IVUS and OCT to enable simultaneous and co-registered imaging of coronary arteries – – Company showcasing its...
TORONTO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- CONAVI MEDICAL CORP. (TSXV: CNVI) (“CONAVI MEDICAL” or the “Company”), a commercial stage company focused on designing, manufacturing, and marketing...
TORONTO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (formerly, “Titan Medical Inc.”) (“Conavi” or the “Company”) (TSXV: CNVI) is pleased to announce that, pursuant to its press...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.03 | -4.54545454545 | 0.66 | 0.78 | 0.61 | 10639 | 0.6454944 | CS |
4 | -0.2 | -24.0963855422 | 0.83 | 0.83 | 0.5 | 10453 | 0.66347535 | CS |
12 | -0.62 | -49.6 | 1.25 | 1.52 | 0.5 | 10372 | 0.89905129 | CS |
26 | -0.62 | -49.6 | 1.25 | 1.52 | 0.5 | 10372 | 0.89905129 | CS |
52 | -0.62 | -49.6 | 1.25 | 1.52 | 0.5 | 10372 | 0.89905129 | CS |
156 | -0.62 | -49.6 | 1.25 | 1.52 | 0.5 | 10372 | 0.89905129 | CS |
260 | -0.62 | -49.6 | 1.25 | 1.52 | 0.5 | 10372 | 0.89905129 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions